Literature DB >> 7334444

The amblyopic schoolgirl syndrome.

M I Mäntyjärvi.   

Abstract

The occurrence of psychogenic amblyopia in a population of school children was studied. From the population of 14,000 school children under the surveillance of school nurses and doctors, 2280 were referred to the author for an ophthalmological examination during a two-year period. Forty children (1.75%) were diagnosed as having psychogenic amblyopia corresponding to an incidence of 1.4/1000/year. Psychogenic amblyopia was characterized by a high percentage of girls (48 out of 52) and the highest occurrence at the age of 9 to 11 years. There was a wide variation of the duration of the condition, but 37% of the patients recovered within one year. A psychological cause for amblyopia could be revealed in only a few cases. According to the present study psychogenic amblyopia can occur at a relatively high incidence. Awareness of this condition could spare these children from straining, expensive tests.

Entities:  

Mesh:

Year:  1981        PMID: 7334444     DOI: 10.3928/0191-3913-19811101-08

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  4 in total

1.  Paediatric ophthalmology: Things that do not require referral.

Authors:  William N Clarke
Journal:  Paediatr Child Health       Date:  2005-09       Impact factor: 2.253

2.  Medically unexplained visual loss in children and young people: an observational single site study of incidence and outcomes.

Authors:  M C Daniel; A Coughtrey; I Heyman; A H Dahlmann-Noor
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

3.  Functional Visual Loss.

Authors:  Kenneth S. Shindler; Steven L. Galetta; Nicholas J. Volpe
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

4.  An atypical presentation of functional visual loss: A case report.

Authors:  Junkyu Chung; Kyung Hyun Jin; Jaheon Kang; Tae Gi Kim
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.